TruBridge, Inc. $TBRG Shares Sold by Truffle Hound Capital LLC

by · The Markets Daily

Truffle Hound Capital LLC trimmed its holdings in TruBridge, Inc. (NASDAQ:TBRG – Free Report) by 94.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,000 shares of the company’s stock after selling 160,000 shares during the period. Truffle Hound Capital LLC owned about 0.07% of TruBridge worth $234,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Kingsview Wealth Management LLC bought a new stake in shares of TruBridge in the first quarter worth $240,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in TruBridge during the 1st quarter worth $370,000. Jefferies Financial Group Inc. bought a new stake in shares of TruBridge in the 1st quarter worth about $256,000. Vanguard Group Inc. increased its position in shares of TruBridge by 2.6% in the 1st quarter. Vanguard Group Inc. now owns 663,862 shares of the company’s stock worth $18,269,000 after purchasing an additional 16,715 shares during the last quarter. Finally, Invesco Ltd. raised its stake in shares of TruBridge by 177.7% in the 1st quarter. Invesco Ltd. now owns 151,489 shares of the company’s stock valued at $4,169,000 after purchasing an additional 96,931 shares in the last quarter. Institutional investors and hedge funds own 88.64% of the company’s stock.

TruBridge Price Performance

Shares of NASDAQ:TBRG opened at $20.51 on Tuesday. The company has a market cap of $307.83 million, a PE ratio of -24.42 and a beta of 0.57. TruBridge, Inc. has a fifty-two week low of $15.69 and a fifty-two week high of $32.00. The firm has a 50-day simple moving average of $20.11 and a 200 day simple moving average of $21.64. The company has a quick ratio of 1.79, a current ratio of 1.80 and a debt-to-equity ratio of 0.94.

TruBridge (NASDAQ:TBRG – Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.48. The company had revenue of $86.11 million during the quarter, compared to the consensus estimate of $85.56 million. TruBridge had a positive return on equity of 3.30% and a negative net margin of 3.63%. TruBridge has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts anticipate that TruBridge, Inc. will post 0.07 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on TBRG shares. BMO Capital Markets started coverage on TruBridge in a research note on Thursday, November 13th. They issued a “market perform” rating and a $19.50 price target for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of TruBridge in a research report on Friday, October 31st. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $25.50.

View Our Latest Stock Report on TBRG

Insider Transactions at TruBridge

In related news, major shareholder Pinetree Capital Ltd. acquired 21,035 shares of the stock in a transaction that occurred on Thursday, November 13th. The stock was purchased at an average cost of $20.41 per share, for a total transaction of $429,324.35. Following the purchase, the insider directly owned 798,220 shares in the company, valued at $16,291,670.20. This represents a 2.71% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. In the last ninety days, insiders purchased 48,903 shares of company stock worth $990,503. Insiders own 10.70% of the company’s stock.

TruBridge Company Profile

(Free Report)

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.

Read More